By downregulating C/EBPβ, the expression of NLRP3 and other inflammasome components is reduced, thereby attenuating the inflammatory response and mitigating neuronal damage in an MPTP neurotoxic model of PD (55, 95). The gene discussed is NLRP3; the disease is Parkinson disease.